Medical Marijuana for HIV/AIDS in Florida
Immune system infection causing debilitating symptoms and treatment side effects.
Medically reviewed by Bruce Stratt, MD
Board-Certified Physician · OMMU Certified · Boca Raton, FL
Overview
HIV (Human Immunodeficiency Virus) attacks the immune system's CD4+ T cells, progressively weakening the body's ability to fight infections. If left untreated, HIV can advance to AIDS (Acquired Immunodeficiency Syndrome). HIV symptoms may include mouth ulcers, sore throat, night sweats, fever, fatigue, and swollen lymph nodes, while AIDS can manifest as recurring fevers, extreme tiredness, profuse night sweats, rapid weight loss, prolonged diarrhea, sores, neurological disorders, depression, and memory loss.
Modern antiretroviral therapy (ART) has transformed HIV into a manageable chronic condition for many patients, but treatment itself can cause significant side effects — including nausea, loss of appetite, insomnia, anxiety, depression, and peripheral neuropathy. These side effects are often severe enough that some patients abandon their antiretroviral therapy entirely, with potentially life-threatening consequences. More than 60% of HIV/AIDS patients already use cannabis as a complementary medicine, according to a study in the Journal of Acquired Immune Deficiency Syndromes — making it one of the most widely self-medicated conditions with cannabis.
Florida explicitly lists HIV/AIDS as a qualifying condition under Statute 381.986. The state has a significant HIV-positive population, particularly in South Florida, and medical cannabis offers these patients a well-studied complementary therapy that can improve both symptom management and medication adherence — a critical factor in long-term outcomes.
How Medical Cannabis May Help
HIV/AIDS is among the most well-researched conditions for medical cannabis, with multiple rigorous randomized controlled trials supporting its use. A landmark trial (Abrams et al., Neurology, 2007) randomized 55 patients with HIV-associated sensory neuropathy to smoked cannabis or placebo. Cannabis reduced daily pain by 34% vs. 17% with placebo (P=0.03), and 52% of cannabis patients achieved clinically meaningful pain reduction vs. 24% on placebo. A second RCT (Ellis et al., Neuropsychopharmacology, 2009) confirmed these results, with 46% of cannabis patients achieving significant pain relief vs. 18% on placebo (effect size 0.60). For appetite and wasting — a leading cause of HIV-related death — the pivotal Beal et al. trial (Journal of Pain and Symptom Management, 1995) led to FDA approval of dronabinol for AIDS-related anorexia. Among 139 patients, dronabinol increased appetite by 38% vs. 8% with placebo (P=0.015), improved mood, and decreased nausea. Weight was stabilized in dronabinol patients while placebo recipients continued losing weight. Crucially, patients who use medical cannabis alongside their ART medications are significantly more likely to maintain adherence to their antiretroviral therapy — cannabis reduces the gastrointestinal side effects that cause many patients to discontinue treatment. Short-term clinical studies have not found that cannabis adversely affects HIV viral load or CD4 cell counts. Cannabis also serves as a mood booster, helping combat the anxiety, depression, and mood swings that are common among HIV-positive individuals. Dr. Stratt works with each patient's infectious disease physician to ensure cannabis therapy complements their ART regimen.
Individual results vary. Consult with Dr. Stratt to understand how cannabis therapy may apply to your specific situation.
What to Bring to Your Appointment
Bring a valid Florida ID and documentation from your infectious disease physician or HIV specialist confirming diagnosis, current ART regimen documentation, and notes on specific symptoms being treated.
Frequently Asked Questions
Related Articles
Patient Resources
Get Your Medical Marijuana Card for HIV/AIDS
Schedule your evaluation with Dr. Stratt. Same-day state registry submissions for qualifying patients.